C ollagen membranes are widely used for bone and connective tissue augmentation techniques such as guided tissue regeneration/guided bone regeneration (GBR) due to their biocompatibility and wound healing capabilities. [1] [2] [3] [4] Collagen membranes promote the rapid ingrowth and repopulation of various types of cells from the surrounding tissues by creating a space-making ability later used for tissue repopulation. 1, 5, 6 Commonly utilized membranes include porcine-derived collagen membranes, which are approved for soft tissue, connective tissue, and bone tissue regeneration, and represent necessary biomaterials commonly utilized in periodontal and implant surgery. 7, 8 Various types of collagen membranes are available, including porcine pericardium collagen membrane (PPCM) and porcine dermis-derived collagen membrane (PDCM). These collagen membranes are constructed of native collagen type I/III without artificial crosslinking and provide ideal properties for vascular formation with the ability to degrade over time. 9, 10 Nevertheless, the regenerative potential of collagen membranes is limited to their osteoconductive surfaces with no osteoinductive potential. 11 For these reasons, the use of collagen membranes is often combined with recombinant human bone morphogenetic proteins (rhBMPs) to increase their osteoinductive and osteopromotive potential. 11 They are considered ideal carriers for growth factor delivery able to release recombinant proteins over time as well as during their gradual degradation. 12 rhBMP-2 has been the most commonly used growth factor for bone regenerative procedures in dentistry during GBR techniques due to its potent osteoinductive potential. 13, 14 Furthermore, in many studies, collagen products have been shown to successfully act as efficient carriers for rhBMP-2 delivery. [15] [16] [17] [18] [19] Despite the widespread use of rhBMP-2, many investigators may be surprised to learn that previous adenovirus experiments (gene therapy) have actually shown that BMP-9 induces greater osteogenic potential compared with BMP-2. [20] [21] [22] [23] While these previous studies utilized adenovirus transfection experiments still not approved by the U.S. Food and Drug Administration, [20] [21] [22] [23] the present group of authors recently reported that rhBMP-9 also strongly accelerated osteoblast differentiation compared with rhBMP-2. 24, 25 Therefore, the aim of the present study was to determine which type of collagen membrane (PPCM or PDCM) has a better influence on the adsorption/release of rhBMPs, as well as its effect on cell behavior.
MATERIALS AND METHODS

Reagents and Cell Line
Recombinant human BMP-2 and BMP-9 were purchased from R&D Systems. The native PPCM utilized (Jason membrane) and the porcine dermis collagen membrane (PDCM) utilized (mucoderm) were both kindly provided by Botiss. Both products are composed of mainly collagen type I, and to a lower degree, collagen type III. For all in vitro experiments, the following four groups for each collagen membrane were examined: (1) tissue culture plastic (control), (2) collagen membrane only, (3) collagen membrane + BMP-2 (100 ng/mL), and (4) collagen membrane + BMP-9 (100 ng/mL). Undifferentiated mouse bone stromal cell-line ST2 was obtained from RIKEN Cell Bank. Cells were cultured in a humidified atmosphere at 37°C in growth medium consisting of Dulbecco's modified Eagle's medium (DMEM; Gibco, Life Technologies), 10% fetal bovine serum (FBS; Gibco), and antibiotics (Gibco). Each collagen membrane was placed at the bottom of 24-well plates and precoated with rhBMP-2 or rhBMP-9 in DMEM for 5 minutes prior to cell seeding. Then, cells were seeded at a density of 10,000 cells in 24-well plates for cell adhesion and proliferation experiments and 50,000 cells per well in 24-well plates for real-time polymerase chain reaction (PCR), alkaline phosphatase (ALP) assay, and alizarin red experiments. For experiments lasting longer than 5 days, the medium was replaced twice weekly.
Scanning Electron Microscopy Images
Collagen membrane samples were sputter-coated using an ion coater device with 10 nm of gold and analyzed microscopically using a scanning electron microscope as previously described. 26 
BMP-2 and BMP-9 Adsorption and Release Kinetics Quantification with ELISA
To determine the quantity of rhBMP-2 and rhBMP-9 adsorption to PPCM or PDCM, enzyme-linked immunosorbent assay (ELISA) quantification assay was utilized. Briefly, after the coating period incubation of 100 ng/ mL of rhBMP-2 or rhBMP-9 onto PPCM and PDCM at 37°C in a shaking incubator, the remaining phosphatebuffered saline solution, containing unattached protein, was collected and quantified by an ELISA Duoset kit for BMP-2 (DY355; range = 46.90 to 3,000 pg/mL, R&D Systems) and BMP-9 (DY3209; range = 15.60 to 1,000 pg/mL, R&D Systems). Subtraction of the total coated protein from the amount of unadsorbed protein was used to determine the amount of adsorbed material to the surface of PPCM and PDCM as previously described. 27 Furthermore, to determine the quantity of rhBMP-2/rhBMP-9 protein being released from PPCM and PDCM over time, coated grafts were soaked in 1 mL of phosphate-buffered saline, and samples were collected at various time points including 15 minutes, 1 hour, 8 hours, 24 hours, 3 days, and 10 days. All samples were quantified in duplicate, and three independent experiments were performed.
Adhesion and Proliferation Assay
Cells were quantified using an MTS assay (Promega) using an ELx808 Absorbance Reader (BIO-TEK) at 8 hours for cell adhesion and at 1, 3, and 5 days for cell proliferation after cell seeding as previously described. 28 
Real-Time PCR Analysis for Osteoblast Differentiation Markers
Total RNA was isolated using High Pure RNA Isolation Kit (Roche) at 3 and 14 days for osteoblast differentiation markers. Primers of runt-related transcription factor 2 (Runx2), ALP, osteocalcin, and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) were fabricated with primer sequences according to Table 1 . Real-time PCR was performed using Roche FastStart Universal SYBR Green Master and quantified on an Applied Biosystems 7500 Real-Time PCR Machine (Biosystems, Life Technologies). A Nanodrop 2000c (Thermo) was used to quantify total RNA levels. The ∆∆Ct method was used to calculate gene expression levels normalized to GAPDH values and calibrated to control samples.
ALP Stain Assay
At 7 days, ALP activity was monitored using Leukocyte alkaline phosphatase kit (procedure No. 86, Sigma) as previously described. 25 ST2 cells were fixed by immersion in a citrate-acetone-formaldehyde fixative solution for 5 minutes. Alkaline dye mixture was prepared by mixing 1 mL of sodium nitrite solution and 1 mL of fast red violet alkaline solution dissolved in 45 mL of deionized water and 1 mL of Naphtol AS-Bl alkaline solution. Surfaces were then placed in alkaline dye mixture solution for 20 minutes protected from light followed by rinsing in deionized water. All images were captured on a Wild Heerbrugg M400 ZOOM Makroskop (Wild Heerbrugg) at the same magnification and light intensity and imported into ImageJ software (National Institutes of Health). Thresholding was used to generate percent stained values for each field of view.
Mineralization Assay
ST2 cells were seeded in 24-well plates at a density of 50,000 cells per well on either membrane in osteogenic differentiation medium, which consisted of DMEM supplemented with 10% FBS, 1% antibiotics, 50 μg/mL ascorbic acid (Sigma), and 10 mM β-glycerophosphate (Sigma) to promote osteoblast differentiation as previously described. 29 At 14 days after ST2 cell seeding, cells were fixed in 96% ethanol for 15 minutes and stained with 0.2% alizarin red solution (Alizarin Red S, Sigma) in deionized water (pH 6.4) at room temperature for 1 hour as previously described. 25, 29 All images were captured and the percentage of staining was evaluated in the same manner as the ALP assay.
Statistical Analysis
All experiments were performed in triplicate with three independent experiments for each condition. Data were analyzed for statistical significance using one-way analysis of variance with the Tukey test (*P < .05 was considered significant) by GraphPad Prism 6.0 software (GraphPad Software).
RESULTS
Surface Characteristics of Collagen Membranes and BMP Adsorption and Release Kinetics
In a first experiment, the surface morphology of PPCM and PDCM was investigated via scanning electron microscopy (Fig 1) . The surface of PPCM demonstrated a three-dimensional (3D) porous structure with numerous collagen fibers (Figs 1a and 1c) . PDCM, on the other hand, demonstrated a more densely structured outer surface with few pores (Figs 1b and 1d) . Thereafter, the potential of PPCM and PDCM to adsorb and release BMP-2 and BMP-9 was investigated by ELISA ( Fig  2) . The total amount of adsorbed BMP-2 and BMP-9 to collagen membrane after 5 minutes revealed a nearly 90% adsorption for both collagen membranes, and after a 10-day period, approximately 50% of the initial BMP-2 and BMP-9 loaded onto collagen membranes was released (Figs 2a and 2b) . Interestingly, BMP-2 showed significantly more adsorption and retention over time up to 10 days on PPCM compared with PDCM (Fig 2a) . On the contrary, BMP-9 demonstrated no significant difference in its adsorption between PPCM and PDCM but higher retention on PDCM from 1 hour up to 10 days compared with PPCM (Fig 2b) .
Effects of rhBMP-2 and rhBMP-9 Loaded Collagen Membranes on ST2 Cell Adhesion and Proliferation
Thereafter, the effects of rhBMP-2 and rhBMP-9 loaded on collagen membranes were investigated on ST2 cell adhesion at 8 hours and cell proliferation at 1, 3, and 5 days postseeding (Fig 3) . It was first observed that PPCM significantly decreased ST2 cell attachment compared with the control at 8 hours after cell seeding (Fig 3a) . Interestingly, cell adhesion increased on collagen membrane + BMP-2 samples compared with PPCM alone or PPCM + BMP-9 (Fig 3a) . While the cell number was decreased on PPCM, PDCM displayed no significant changes between all groups, and thereby, better cell attachment was observed (Fig 3b) . Moreover, PPCM and PDCM were tested for their abilities to induce cell proliferation (Figs 3c and 3d) . While both PPCM and PDCM significantly inhibited cell growth compared with the control, it was once again observed that cell numbers were higher on PDCM compared with PPCM (Figs 3c and 3d) .
Effects of rhBMP-2 and rhBMP-9 Loaded onto Collagen Membranes on Osteoblastic Differentiation
Thereafter, the osteogenic differentiation potentials of rhBMP-2 and rhBMP-9 precoated on PPCM and PDCM were investigated by ALP activity (Fig 4) , realtime PCR (Fig 5) , and alizarin red staining (Fig 6) . It was first observed that both collagen membranes alone did not affect ALP activity compared with the control (Fig 4) . The additional combination of rhBMP-2 and rhBMP-9 induced higher levels of ALP activity compared with collagen membranes alone or the control (Figs 4g and 4h) . Interestingly, while rhBMP-9 significantly upregulated ALP activity on both collagen membranes, rhBMP-2 was only able to significantly upregulate ALP activity on PDCM membranes (Figs 4g and 4h) . While all PDCM groups nonsignificantly decreased Runx2 mRNA levels at 3 days, no difference was observed at 14 days compared with the control (Figs 5a  and 5b) . Interestingly, PPCM + BMP-9 samples at 14 days and PDCM + BMP-9 at 3 days upregulated ALP mRNA levels up to fourfold compared with the control (Figs 5c and 5d) . In a similar manner, collagen membranes + BMP-9 samples significantly increased osteocalcin mRNA levels at 14 days postseeding compared with the control, whereas no difference was observed with rhBMP-2 (Figs 5e and 5f ). Lastly, alizarin red staining was performed to assess mineralization potential of rhBMP-2 and rh-BMP-9 when coated onto both collagen membranes (Fig 6) . It was found at 14 days after cell seeding that on PPCM membranes, rhBMP-9 induced significantly higher alizarin red staining compared with the control and PPCM membranes alone, whereas PDCM membranes with either rhBMP-2 or rhBMP-9 induced significantly higher alizarin red staining compared with the control or PDCM membranes alone (Figs 6e to 6h and 6j).
DISCUSSION
The aim of the present study was to assess the boneinducing properties of two porcine-derived collagen membranes commonly utilized in regenerative dentistry when loaded with rhBMP-2 and rhBMP-9. In general, bone augmentation procedures have been characterized as derived from four principal methods including: (1) osteoinduction, which utilizes appropriate growth factors; (2) osteoconduction, which is the ability for the scaffold to conduce new bone formation; (3) distraction osteogenesis, which generates new bone by progressive stretching of divided bone segments; and (4) guided tissue regeneration/GBR, which allows space maintenance by barrier membranes to be later occupied with bone. 30 The present study investigated the osteogenic possibilities of rhBMP-2 and rhBMP-9 as osteoinductive factors, and two kinds of porcine native collagen membranes as GBR membranes, thereby directly assessing the bone augmentation principles (1), (2) , and (4).
The first set of experiments investigating the surface morphologic features of both PPCM and PDCM demonstrated 3D constructs with numerous collagen fibers expecting for cell ingrowth, namely, in the PPCM (Fig 1) . Interestingly, PDCM showed a denser structure compared with PPCM, and these differences are discussed later as potential reasons for the observed cellular differences. Extracellular collagenous matrix acts at 3 and 14 days after seeding (*denotes significant difference, P < .05; **denotes significantly higher than all other treatment modalities, P < .05). * * as a 3D scaffold to allow cell ingrowth and repopulation from surrounding tissues. 1 In addition, collagen serves as an excellent carrier system for growth factors, namely, BMPs. Both PPCM and PDCM behaved similarly by demonstrating approximately 90% of BMP adsorption onto both PPCM and PDCM and showing slow BMP release over time up to 10 days overall (Fig  2) . The sustained delivery of BMPs to bone defects is considered advantageous for long-term bone regeneration compared with a single high-dose burst of BMPs. 31, 32 Therefore, it may be suggested from the present study that both PPCM and PDCM may serve as suitable carrier systems for either rhBMP-2 or rhBMP-9. Furthermore, interestingly, PPCM demonstrated significantly more adsorption and retention of BMP-2 over time, and PDCM demonstrated more retention of BMP-9 from 1 hour to 10 days compared with the other collagen membrane (Fig 2) . This difference of kinetics on two collagen membranes might result from the variances of protein 3D structures and binding sites between rhBMP-2 and rhBMP-9.
Thereafter, the cell behavior on collagen membranes combined with rhBMP-2 and rhBMP-9 was investigated on ST2 cell attachment, proliferation, and differentiation (Figs 3 to 6) . PPCM demonstrated less cell adhesion compared with the control at 8 hours after cell seeding. Interestingly, however, PDCM showed better cell attachment and comparable results to the control (Fig 3) . One potential explanation for this may be because PDCM membranes are denser by nature, thereby providing a more easily attachable surface for incoming osteoblasts. It was also found that the additional use of rhBMP-2/rhBMP-9 did not influence cell proliferation on either collagen membrane (Figs 3c and  3d) . Treatment by both collagen membranes showed fewer cell numbers compared with the control; however, cell growth on both collagen membranes was constantly observed for 5 days, and additional rhBMP-2/ rhBMP-9 coating did not influence cell adhesion and proliferation, which suggested relatively biocompatible effects of PPCM and PDCM combined with rh-BMP-2 or rhBMP-9. The authors' previous findings have also shown that rhBMP-9 has little effect on cell proliferation and mainly induces rapid differentiation toward osteoblasts. 24, 25 Thereafter, osteogenic differentiation was investigated. Although the combination of rhBMP-2 on PDCM increased alizarin red staining (Fig 6j) , rhBMP-2 on PPCM did not seem to promote marked increases in osteoblast differentiation. Most interestingly, rhBMP-9 treated samples, regardless of whether they were coated on PPCM or PDCM, demonstrated more potent osteogenic cell differentiation by demonstrating significant increases in ALP and OCN mRNA levels at either 3 or 14 days, ALP activity at 7 days, and alizarin red staining at 14 days (Figs 4 to 6). These results are consistent with previous reports by the present authors that rhBMP-9 had the greatest influence on osteoblast differentiation in vitro. 24, 25 Interestingly, while PPCM seemed to increase cell attachment by providing a smoother biomaterial surface, PDCM seemed to favor osteoblast differentiation by providing a more roughened surface. It remains to be further investigated what the molecular mechanism is for these findings and to determine by which signaling pathways rhBMP-9 is able to induce more rapid cellular osteoblast differentiation on the various membranes found in this study. Furthermore, there remains to date no in vivo data comparing the regenerative potential of rhBMP-2 to rhBMP-9 for the regeneration of animal bone defects. Therefore, future animal study is also of vast importance to further characterize the regenerative potential of rhBMP-9 in comparison to the current gold standard rhBMP-2.
CONCLUSIONS
The results from this study demonstrate that both types of porcine-derived collagen membranes behaved as suitable carriers of rhBMP-2 and rhBMP-9, and both collagen membranes combined with rhBMP-9 demonstrated significantly superior osteopromotive properties compared with the control samples. Interestingly, it was further found that slight differences were observed between two kinds of collagen membranes, including the fact that PDCM membranes seemed to improve cell attachment and proliferation and also seemed to promote greater ALP activity of both rhBMP-2 and rhBMP-9, whereas PPCM membranes showed greater ALP activity when combined with rhBMP-9 only. Nevertheless, these studies point to the necessity to further evaluate both membranes and growth factors in various animal models to further characterize the regenerative potential of both rhBMP-2/ rhBMP-9 in vivo for bone augmentation procedures.
